Business Standard

Lincoln Pharmaceuticals standalone net profit rises 25.22% in the September 2017 quarter

Image

Capital Market

Sales rise 22.66% to Rs 85.64 crore

Net profit of Lincoln Pharmaceuticals rose 25.22% to Rs 9.93 crore in the quarter ended September 2017 as against Rs 7.93 crore during the previous quarter ended September 2016. Sales rose 22.66% to Rs 85.64 crore in the quarter ended September 2017 as against Rs 69.82 crore during the previous quarter ended September 2016. ParticularsQuarter EndedSep. 2017Sep. 2016% Var.Sales85.6469.82 23 OPM %15.1713.56 -PBDT14.8711.46 30 PBT13.5010.60 27 NP9.937.93 25

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Dec 13 2017 | 4:54 PM IST

Explore News